VESANOID إسرائيل - الإنجليزية - Ministry of Health

vesanoid

tzamal bio-pharma ltd - tretinoin - capsules - tretinoin 10 mg - tretinoin - tretinoin - induction of remission in acute promyelocytic leukemia.

AGGRASTAT إسرائيل - الإنجليزية - Ministry of Health

aggrastat

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - solution for infusion - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

DICLECTIN  إسرائيل - الإنجليزية - Ministry of Health

diclectin

tzamal bio-pharma ltd - doxylamine succinate; pyridoxine (vit b6) hydrochloride - tablets delayed release - pyridoxine (vit b6) hydrochloride 10 mg; doxylamine succinate 10 mg - doxylamine - diclectin® is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.

DICLECTIN  إسرائيل - الإنجليزية - Ministry of Health

diclectin

tzamal bio-pharma ltd - doxylamine succinate; pyridoxine (vit b6) hydrochloride - tablets delayed release - pyridoxine (vit b6) hydrochloride 10 mg; doxylamine succinate 10 mg - doxylamine - diclectin® is indicated for the treatment of nausea and vomiting of pregnancy inwomen who do not respond to conservative management.

VESANOID إسرائيل - الإنجليزية - Ministry of Health

vesanoid

tzamal bio-pharma ltd - tretinoin - capsules - tretinoin 10 mg - tretinoin - induction of remission in acute promyelocytic leukemia.

VESANOID إسرائيل - الإنجليزية - Ministry of Health

vesanoid

tzamal bio-pharma ltd - tretinoin - capsules - tretinoin 10 mg - tretinoin - induction of remission in acute promyelocytic leukemia.

VESANOID إسرائيل - الإنجليزية - Ministry of Health

vesanoid

tzamal bio-pharma ltd - tretinoin - capsules - tretinoin 10 mg - tretinoin - induction of remission in acute promyelocytic leukemia.

VESANOID إسرائيل - الإنجليزية - Ministry of Health

vesanoid

tzamal bio-pharma ltd - tretinoin - capsules - tretinoin 10 mg - tretinoin - induction of remission in acute promyelocytic leukemia.

FOMICYT 2 G. إسرائيل - الإنجليزية - Ministry of Health

fomicyt 2 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 2 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.

FOMICYT 4 G. إسرائيل - الإنجليزية - Ministry of Health

fomicyt 4 g.

tzamal bio-pharma ltd - fosfomycin as sodium - powder for solution for infusion - fosfomycin as sodium 4 g - fosfomycin - fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:• complicated urinary tract infections• infective endocarditis• bone and joint infections• hospital-acquired pneumonia, including ventilator-associated pneumonia• complicated skin and soft tissue infection• bacterial meningitis• complicated intra-abdominal infections• bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveconsideration should be given to official guidance on the appropriate use of antibacterial agents.